Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
15 April, 2021 19:46 IST
Unichem Lab gets USFDA nod for Guanfacine Tablets
Source: IRIS | 05 Mar, 2021, 01.03PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

 Unichem Laboratories, a leading pharmaceutical company in India announced that it has received ANDA approval for its Guanfacine Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENEX (Guanfacine) Tablets 1 mg and 2 mg of Promius Pharma LLC.

Guanfacine Tablets are indicated in the management of hypertension. The product will be commercialized from Unichem's Ghaziabad Plant.

Shares of the company gained Rs 1.5, or 0.44%, to trade at  Rs 345.  The total volume of shares traded  was  12,442 at the BSE (11.39 a.m., Friday).



 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Nagpur Power & Industries gets nod to increase stake in subsidiary company - 14-Apr-2021 20:29
Inox Leisure starts commercial operations of Multiplex Cinema Theatre in Bangalore - 14-Apr-2021 19:03
Venus Remedies enters into partnership with West Pharmaceutical Services - 14-Apr-2021 17:30
IDBI Capital maintains Accumulate on TCS with target of Rs 3,530 - 14-Apr-2021 12:31
TCS 4QFY21: Strong FY21 exit rate and deal wins to drive growth in FY22: Motilal Oswal - 14-Apr-2021 09:21
ELGi partners with Italian Red Cross to maintain critical COVID-19 response vehicles - 14-Apr-2021 08:50
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer